Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
This study has been completed.
Sponsor:
Eli Lilly and Company
Collaborator:
University of California, San Francisco
Information provided by:
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00402116
First received: November 17, 2006
Last updated: October 25, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | October 25, 2010 |